In this episode, DLA Piper partner Danny Tobey is joined by Aviva Wein, Assistant General Counsel at Johnson & Johnson, to discuss how medical device and pharmaceutical companies are future-proofing their innovations in artificial intelligence as new regulations and risks arise.
| less than a minute read
AI risk assessments: Future-proofing your innovation when rules can change mid-game - At the Intersection of Science and Law Podcast Series
Get in touch
Get in touch
Get in touch
Get in touch
/Passle/596df0e43d947619ec025f26/MediaLibrary/Images/2024-10-08-10-50-28-575-67050e74c71f57809f6d0411.jpg)
Introduction Over the next 2 months, the DLA Piper Life Sciences Blog: Cortex will feature a series of articles providing an insight into...
Latest Insights
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2025-03-17-10-33-28-399-67d7fa78bf14cca0f5e2c402.jpg)
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2025-02-05-11-45-56-829-67a34f74966bf3c993454c6a.jpg)
/Passle/596df0e43d947619ec025f26/MediaLibrary/Document/2025-02-04-16-21-29-274-A27003_Life_Sciences_January_2025_Brochure_English_V1_afterchange_thumbnail_1.png)
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2025-01-24-09-38-32-700-67935f98312d8a93f10c9c08.jpg)
